Laura Brege's Net Worth
$12.4 Million
Who is Laura Brege?
Laura Brege has an estimated net worth of $12.4 Million. This is based on reported shares across multiple companies, which include Pacira BioSciences, Inc., DYNAVAX TECHNOLOGIES CORP, Edgewise Therapeutics, Inc., Mirum Pharmaceuticals, Inc., ACADIA PHARMACEUTICALS INC, ARATANA THERAPEUTICS, INC., DELCATH SYSTEMS, INC., ANGIOTECH PHARMACEUTICALS INC, ONYX PHARMACEUTICALS INC, and PORTOLA PHARMACEUTICALS INC.
SEC CIK
Laura Brege's CIK is 0001365619
Past Insider Trading and Trends
2008 was Laura Brege's most active year for acquiring shares with 11 total transactions. Laura Brege's most active month to acquire stocks was the month of May. 2007 was Laura Brege's most active year for disposing of shares, totalling 21 transactions. Laura Brege's most active month to dispose stocks was the month of July. 2007 saw Laura Brege paying a total of $772,000.00 for 130,000 shares, this is the most they've acquired in one year. In 2013 Laura Brege cashed out on 200,540 shares for a total of $2,301,312.65, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Pacira BioSciences, Inc. (PCRX) Snapshot price: $28.68
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +18.59% | 1.77K |
—
|
—
| 11.32K |
Jun 14
| |||
Form 4
| -5.91% | -600.00 |
$38.74 | -$23,244.00 | 9.55K |
Jun 5
| |||
Form 4
|
—
|
0
|
$35.31 | -$75,740.00 | 10.15K |
Scheduled
|
Apr 3
| ||
Form 4
| +12.91% | 1.16K |
—
|
—
| 10.15K |
Jun 8
| |||
Form 4
| +13.46% | 1.07K |
—
|
—
| 8.99K |
Jun 9
| |||
Form 4
|
—
|
0
|
$39.97 | -$623,640.00 | 7.92K |
Nov 16
| |||
Form 4
| +18.92% | 1.26K |
—
|
—
| 7.92K |
Jun 9
| |||
Form 4
| -23.97% | -2.10K |
$48.70 | -$102,270.00 | 6.66K |
Jun 5
| |||
Form 4
| +89.35% | 4.13K |
—
|
—
| 8.76K |
Jun 5
| |||
Form 4
| +20.34% | 782 |
—
|
—
| 4.63K |
Jun 13
| |||
Form 4
| +54.54% | 1.36K |
—
|
—
| 3.85K |
Jun 14
| |||
Form 4
| +148.80% | 1.49K |
—
|
—
| 2.49K |
Jun 15
| |||
Form 4
| -50.00% | -1.00K |
$46.95 | -$46,950.00 | 1K |
Scheduled
|
Jun 6
| ||
Form 4
|
∞
| 2K |
—
|
—
| 2K |
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
$42.81 | -$620,840.00 |
0
|
Scheduled
|
May 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $12.905
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
| No matching records found | |||||||||
Edgewise Therapeutics, Inc. (EWTX) Snapshot price: $19.92
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mirum Pharmaceuticals, Inc. (MIRM) Snapshot price: $26.82
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
∞
| 10K |
$11.22 | $112,200.00 | 10K |
Sep 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $25.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -25.00% | -4.50K |
$24.87 | -$111,906.00 | 13.5K |
Jun 12
| |||
Form 4
|
∞
| 18K |
—
|
—
| 18K |
Jun 22 - Jun 1
| |||
Form 4
|
—
|
0
|
$17.63 | -$15,500.00 |
0
|
Scheduled
|
Jan 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
$21.97 | -$404,400.00 |
0
|
Scheduled
|
Jan 7
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
$11.08 | -$178,441.00 |
0
|
Scheduled
|
Jan 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
$19.15 | -$545,742.50 |
0
|
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
$17.69 | -$318,849.00 |
0
|
Scheduled
|
Feb 11
| ||
Form 4
|
—
|
0
|
$14.91 | -$263,169.00 |
0
|
Scheduled
|
Sep 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
$12.15 | -$296,926.58 |
0
|
Scheduled
|
Apr 4
| ||
Form 4
|
—
|
0
|
$12.77 | -$228,164.00 |
0
|
Scheduled
|
Jan 15
| ||
Form 4
|
—
|
0
|
$12.39 | -$972,912.20 |
0
|
Scheduled
|
Dec 10
| ||
Form 4
|
—
|
0
|
$11.47 | -$203,256.00 |
0
|
Scheduled
|
Oct 10
| ||
Form 4
|
—
|
0
|
$12.05 | -$992,146.43 |
0
|
Scheduled
|
Sep 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||